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ABSTRACT 
This contribution examines the application of near infra-red (NIR) quantum dot (QD) containing 
films for cholesterol detection. Water-soluble, 2-(dimethylamino)ethanthiol (DAET) protected 
800 nm CdSeTe/ZnS core-shell QDs were prepared and incorporated into a chitosan film. The 
NIR electrogenerated chemiluminescence (ECL) of the QD/chitosan films upon reaction with 
H2O2 co-reactant (produced as a by-product of cholesterol oxidase-catalysed oxidation of 
cholesterol) gave a strong ECL signal at -1.35 V vs. Ag/AgCl. The sensor displayed a linear 
response over the clinically relevant range (0.25  >FKROHVWHURO@  5 mM) allowing the rapid 
detection of cholesterol and providing a platform for future development. Significantly, this NIR 
emission has been shown to exhibit excellent penetrability through biological samples, and will 
likely be at the forefront of development in the biosensing and imaging fields for the foreseeable 
future.  
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INTRODUCTION 
The burden of high cholesterol levels on healthcare services worldwide is becoming an 
increasing problem as over-eating and lack of exercise drive the current global obesity epidemic. 
Hypercholesterolemia (total blood cholesterol concentrations above 5mM),1caused by a diet high 
in saturated fat2 results in the accumulation of cholesterol on arterial walls, leading to  hardening, 
thinning and chronic inflammation (atherosclerosis)3Patients suffering from this indisposition are 
at a proven risk of developing more serious cardiac related diseases such as ischaemic heart 
disease4-5, stroke6 and peripheral vascular disease.7 Detection of elevated cholesterol levels is 
therefore key in implementing a strategic health plan to reduce total cholesterol blood 
concentrations and minimize the risk of progression to more serious diseases.8Literature in this 
area indicates that it is the levels of high density and low density lipoproteins that are most 
strongly indicative of cardiovascular disease risk.8-10 Both low levels of high density lipoproteins 
(HDL) and high levels of low density lipoproteins (LDL) are associated with an increased risk of 
CVD.11 This is because oxidation of LDL tends to promote the development of atherosclerosis,12 
whereas HDL has a host of benefits that fight its onset.13 Levels of these lipoproteins can be 
estimated via their associated cholesterol concentrations.14 As such the requirement for accurate, 
robust and selective biosensors for cholesterol detection is of clear clinical importance. 
 A number of cholesterol detection methods based on spectrophotometric15, HPLC16 and 
gas-liquid chromatography17 have previously been reported. However, these tend to require 
expensive equipment, extensive sample preparation and suffer from poorer sensitivity and 
selectivity when compared to enzymatic based techniques. As such the majority of cholesterol 
biosensors incorporate cholesterol oxidase (ChOx) into their design and use electrochemical 
detection (amperometric) of hydrogen peroxide, produced as a byproduct in the ChOx-catalysed 
oxidation of cholesterol in the presence of oxygen.18-22 The presence of ChOx infers excellent 
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inherent selectivity, avoiding the need for lengthy sample preparation procedures and reducing 
costs, however, interference from other analytes present in the sample, as with any analysis, can 
lead to errors in interpretation.  
 ECL has been used extensively as a detection method in bio-sensing because of its 
advantages over other detection techniques. Excellent sensitivity is achieved as no light source is 
required, resulting in minimal background light intensity23, whilst scattered light and 
interferences from emission by impurities or other analytes is effectively eliminated.24 Combined 
with the specificity of the ECL reaction, these attributes produce a technique that is ideally suited 
for detecting low concentration target analytes in complex matrices with a good signal to noise 
ratio.25-28 These benefits have allowed the development of a variety of ECL-based biosensors for 
cholesterol detection. Marquette et al29 developed a biosensor based on the ECL of a 
luminol/H2O2 system, with ChOx immobilised in a membrane through which the cholesterol 
samples were passed. Generation of H2O2 in the presence of cholesterol resulted in the emission 
of ECL from luminol, allowing detection down to 0.6nM. Ballesta-Claveret al30 created a 
disposable sensor that incorporated synthesized luminol copolymers onto which ChOx was 
covalently attached. In the presence of cholesterol, production of H2O2 resulted in the generation 
of ECL from these conducting polymers that showed a linear response to increasing cholesterol 
concentrations. 
 Clearly, one of the most important aspects of enzymatic-based sensors is that the 
bioactivity, stability and specificity of the enzymatic reaction is retained in both the conditions 
and/or immobilization techniques used. A number of immobilization matrices have been reported 
previously, including sol-gel films31-33, polyaniline films34-35, polypyyrole films36-38 and a 
selection of other conducting polymer films.39-41 However, more recently, the use of nano-
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materials as immobilization matrices have been pursued. Their large surface area relative to bulk 
size provides a high enzyme loading ability and a compatible microenvironment allows retention 
of bioactivity. QDs in particular, have found uses in a broad range of bio-sensing applications 
because of their unique optical and electronic properties and have been widely used in ECL 
systems following their discovery as ECL emitters by Bards group in 2002.42 Their high 
quantum efficiency and resistance to photo-bleaching, combined with their size-tuneable 
emission, make them ideal luminophores, whilst their large surface area allows greater 
biomolecule loading than standard emitters. Zhu et al43 developed a cholesterol biosensor with 
ChOx immobilised on gold nanoparticle-decorated multiwalled carbon nanotubes. The use of 
nanoparticles allowed high enzyme loading and fast electron transfer rates with amperometric 
detection being used to determine cholesterol concentrations. Hong et al44 used cupric oxide 
nanoparticles to catalyse the oxidation of luminol by H2O2. The sensitivity of this 
chemiluminescent sensor was improved when compared to the same system with no 
nanoparticles present. 
 However, at the time of writing there does not appear to be any work based on the ECL 
of near-infrared (NIR) QD films for the detection of cholesterol. The benefit of such a system is 
that emission above 800 nm reduces signal interference from whole blood samples, an issue that 
can affect detection systems that use emitters in the visible region. These NIR emitters can 
therefore act as a gateway for development of a cholesterol sensor that can directly analyze 
whole blood samples with no sample pre-treatment. 
 In this work, we have developed a biosensor for cholesterol based on the ECL of 800 nm 
CdSeTe/ZnS core-shell QDs (Figure 1). A glassy carbon electrode (GCE) was modified with a 
QD/chitosan composite. Chitosan was selected as the polymer for film development due to its 
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non-toxicity, good biocompatibility and commercial availability.45-46 This work has shown that 
these water-soluble, NIR-emitting QDs are suitable for use in ECL biosensors and could be 
extremely helpful in the development of novel systems that are able to detect clinically relevant 
analytes directly from clinical samples. They have been used to successfully develop a 
cholesterol detection system with a clinically-relevant linear range, minimizing the requirement 
for sample preparation. Ideally, this system could be used in combination with an agent that has 
the ability to selectively release cholesterol from HDL and LDL prior to its quantification and is 
an area in which future work would focus. 
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EXPERIMENTAL SECTION 
Materials and Methods 
Core-shell CdSeTe/ZnSquantum dots (Qdot® 800 ITK organic quantum dots, 1ȝ0 LQ
decane) were purchased from Invitrogen. Chitosan (medium molecular weight, 75-85% 
deacetylated), phosphate buffered saline (PBS, pH 7.4), hydrogen peroxide, cholesterol, 
cholesterol oxidase (ChOx) from Streptomyces sp., 2-(dimethylamino)ethanthiol (DAET) and 
25% aqueous glutaraldehyde were all purchased from Sigma-Aldrich and used as received. All 
other chemicals were of reagent grade quality and used as received. Human serum samples were 
obtained from Dublin City University following ethical approval and stored at -20°C until use. 
Glassy carbon electrodes (3mm diameter)were purchased from IJ Cambria (UK). They were 
cleaned by successive polishing using 1, DQGȝP alumina slurry, followed by sonication 
in ethanol and water, respectively, for 30 minutes. Measurements involving simultaneous 
detection of light and current utilized a CH instrument model 760D connected to a Hamamatsu 
H6780-20 PMT powered at -950 V.  
During the ECL experiments, 1 mL sample volume was required and run time was 40 s. The 
cell was kept in a light-tight Faraday cage in a specially designed holder configuration where the 
working electrode was positioned directly above the PMT window. All electrochemical 
experiments were carried out using a conventional three-electrode assembly. Potentials are 
quoted versus Ag/AgCl using a platinum wire as counter and all measurements were made at 
room temperature (20°C). All other reagents used were of analytical grade, and all solutions were 
prepared in Milli-Q water PȍFP ECL spectra were recorded on Ocean Optics USB2000+ 
CCD spectrometer using CH instriument electrochemical analyser, CH instrument model 760D.  
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Preparation of water soluble CdSeTe/ZnS core-shell QDs 
The method followed was similar to that developed by Woelfle and Claus47. 0.5 mL of 0.5 M 
DAET in methanol was mixed with 0.25 mL of the CdSeTe/ZnS QDs in decane (1ȝ01LWURJHQ
was bubbled through the solution for 5 minutes, which was then sealed and left stirring overnight 
at room temperature in the dark. The QDs were then precipitated with an excess of acetone 
followed by centrifugation at 5000 rpm for 6 minutes. The filtrate was removed and the 
precipitate was re-dispersed in 0.25 mL of distilled water. These water-soluble QDs were 
centrifuged for a further 6 minutes at 3000 rpm to remove any impurities and then stored in 
darkness in the fridge. 
 
Preparation of CdSeTe/ZnS core-shell QD-chitosan composite film 
0.1% chitosan was prepared by dissolving 1.1 mg chitosan in 1 mL of 1% aqueous acetic acid. 
The QD/chitosan composite was prepared by mixing aliquots of the water-soluble QDs with the 
chitosan solution in a 1:1 (v/v) ratio. This composite was then carefully cast onto the 
electroactive portion of a GCE and allowed to dry in the fridge for 1 hour in the dark. 
 
Cholesterol and cholesterol oxidase solution preparation 
5 mL of Triton X-100 and 5 mL of isopropanol were mixed and heated to 50°C. 0.1933 g of 
cholesterol was slowly added to this solution until fully dissolved and then 40 mL of 0.1 M PBS 
was added with continuous mixing to produce a 10 mM stock solution. A cloudy solution 
resulted, which became clear after cooling. The solution was stored in the fridge (4°C) when not 
in use and required gentle heating, to 35°C, and cooling if it turned cloudy. Aliquots of this stock 
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solution were diluted in Triton X-100:isopropanol:0.1 M PBS (1:1:8) to obtain the required 
cholesterol concentrations for analysis. 
 A 10 mg/mL ChOx stock solution was prepared on the day of use by dissolving 1 mg of 
ChOx LQ  ȝ/ RI GLVWLOOHG ZDWHUA 1 in 10 dilution of this ChOx solution was made in 
cholesterol solutions at varying concentrations, giving a working concentration of 0.1 mg/mL. 
The modified electrode was immersed in these solutions, which had been incubated for 60 
minutes at 45϶C to allow oxidation of cholesterol to occur. The incubation temperature was set at 
45϶C as maximum activity of Cholesterol Oxidase from Streptomyces sp. is achieved at this 
temperature (according to manufacturer). A scanning potential between 0 and -2 V was then 
applied to the modified electrodes and the ECL signal was monitored using a photomultiplier 
tube (PMT). 
 
Preparation of spiked interferent samples 
A 5 mM cholesterol solution was prepared in Triton X-100:isopropanol:0.1 M PBS (1:1:8) to 
which 10 mM urea, 10 mM glucose or 1 mg/mL citric acid was added. This solution was then 
incubated with ChOx as outlined above and the ECL response of the QD/chitosan film was then 
monitored. 
 
Preparation of spiked and unknown human serum samples 
Human serum was mixed 1 to 1 with cholesterol solutions at different concentrations 
containing 0.1 mg/mL ChOx. These solutions were mixed and left to incubate for 60 minutes at 
45϶C and then analyzed by ECL. 
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Preparation of CdSeTe/ZnS core-shell QD-chitosan-ChOx composite film 
Water-soluble CdSeTe/ZnS QDs were dropcast onto the electrode and left to dry in the fridge 
for 1 hour.  0.05% chitosan was then dropcast on top of this film and allowed to dry in the fridge 
for 1 hour. This film was then incubated in 10% glutaraldehyde for 1 hour at room temperature 
followed by washing with distilled water. The electrode was then incubated in a 10 mg/mL 
solution of ChOx for 3 hours at room temperature followed by washing in PBS-Tween and 
distilled water. These films were then immersed in solutions of cholesterol and immediately 
analyzed. 
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RESULTS AND DISCUSSION 
Characterisation of the QD/chitosan composite film. The absorption and emission profiles of 
the QDs are shown in Table 1. Examination of the QDs was undertaken utilizing emission 
spectrometry. The emission maximum for the QDs lies at ~795 nm. This is related to the 
radiative recombination of electrons, which have been excited into higher energy levels of the 
QD following photon absorption, as they return to the ground state.  
The ECL spectrum of the QDs, Fig. 2, shows an emission peak at approximately 810 nm, ~15 
nm longer than the photo-induced emission peaks of the QDs. This red shifted wavelength 
associated with the surface-confined electrochemical reactions leading to emission in the ECL 
process is most likely due to the difference in the reorganization energy of this route when 
compared to standard, optically-induced emission, as seen previously.26-27, 48-50 
The electrochemical characteristics of a blank GCE and the QD/chitosan films in the presence 
and absence of H2O2 and in the presence of cholesterol were investigated using cyclic 
voltammetry (CV) and are shown in Fig. 3. When no QD/chitosan film is present, no discernable 
peaks are observed. Following QD/chitosan film application, a peak is observed at -1.8 V vs. 
Ag/AgCl in all cases. Investigations into this peak (see supplementary data) suggested it was 
related to a secondary reduction of the QDs themselves, which resulted in their destruction. 
When H2O2 is introduced into the system, either directly or via cholesterol oxidation, two 
additional irreversible reduction processes are observed at approximately -1.35 V and -1.55 V vs. 
Ag/AgCl. The peak at -1.35 V is related to the concentration of H2O2 (peak current increases 
with increasing H2O2 concentration ± see supplementary data), suggesting it is associated with its 
direct reduction or the reduction of one of its degradation products, such as the formation of 
hydroxyl ions from hydroxyl radicals. The peak at -1.55 V is likely related to a similar process, 
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but may involve reduction of a species created following electron transfer between film 
components, causing this increase in peak potential.  
In the presence of an incubated cholesterol/ChOx solution, the same reduction peaks are 
observed as when H2O2 is present, indicating that oxidation of cholesterol has been successful 
and H2O2 has been produced following reduction of dissolved oxygen. H2O2 can then act as a co-
reactant for the production of ECL from the QDs through the following electrochemical 
reactions:51-52 
QDs + 1e- ĺ4'V(e-1Se)       (1) 
QDs(e-1Se) + H2O2 ĺQDs + OH- + OH   (2) 
OH + QDs ĺOH- + QDs(h+1Sh)    (3) 
QDs(e-1Se) + OH
ĺOH- + QDs*    (4) 
QDs(e-1Se) + QDs(h
+1Sh)ĺ4'V*   (5) 
4'Vĺ4'V + KȞ (800 nm)    (6) 
Initially, electrons are injected into the 1Se quantum confined orbital of the QDs to create 
electron-injected QD intermediates (equation (1)) that are capable of reducing H2O2 to OH
- and 
OH (equation (2)) following a simulated Haber-Weiss reaction. Typically, this requires 
superoxide, O2
-, generated through the single electron reduction of oxygen. However, in this 
case, QDs(e-1Se) acts as the radical anion in place of superoxide to reduce H2O2 to OH
. This 
hydroxyl radical is the crucial species for ECL production in this system and following its 
formation is reduced in the process of injecting a hole into the 1Sh quantum confined orbital of a 
QD to create hole-injected QDs, QDs(h+1Sh) (equation (3)). This process is favorabledueto the 
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high standard redox potential of the OH-/OH couple. Excited state QDs (QDs*) can then be 
formed via an annihilation or co-reactant pathway. Hole-injected QDs can recombine with 
electron-injected QDs to create QDs* via the annihilation route (equation (5)), whilst reduced 
QDs can also interact directly with OH to create QDs* following the co-reactant route (equation 
(4)). Both of these processes result in the formation of QDs*, which will relax to the ground state 
accompanied by the emission of light at a wavelength determined by the band gap, and therefore 
size, of the QD material. In the presence of H2O2, two ECL peaks were present, which has been 
observed previously.46 The initial peak, ECL-1, was shown to result from the interaction of a 
nanocrystal species formed due the reduction of the QDs and the co-reactants, whilst ECL-2 is 
produced from the interaction of the co-reactants and the assembly of QD reduced nanocrystal 
species. Investigations in this study, showed that ECL-2 is more sensitive to the dissolved H2O2, 
and thus was chosen to detect H2O2 for developing ECL sensing applications of these 
QD/chitosan films. 
 
ECL of the QD/chitosan composite film. Fig. 4 illustrates the ECL response of the 
QD/chitosan composite film as a function of H2O2concentration. An ECL peak is seen at 
approximately -1.35 V vs. Ag/AgCl, with intensity increasing linearly with increasing H2O2 
concentrations from 0.25 to 2 mM. This peak is closely related to the reduction process seen in 
the CVs at a very similar potential, indicating the two events are closely related and that ECL 
emission is dependent upon this process.46 
Reproducibility was improved by using small volumes, below 1.5 PL of QD/chitosan which 
reduced the possibility of aggregation of the QDs in the film which might lead to variations in 
the ECL response.  
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Quantitative Detection of Cholesterol. In the presence of ChOx, H2O2 is produced as a by-
product of cholesterol oxidation and can then act as a co-reactant for the production of QD ECL, 
in the reactions described previously (equations 1 ± 6). As a linear ECL response to H2O2 has 
been achieved, it is proposed that QD/chitosan film ECL could be used for the quantitative 
detection of cholesterol. Fig. 5 shows the ECL response of the QD/chitosan films to increasing 
cholesterol concentrations.  
The ECL signal shows a linear dependence over the range 0.25-5 mM cholesterol. The ECL 
spectrum is consistent with those acquired using H2O2 co-reactant, as shown in Fig. 4. This 
indicates that H2O2 is successfully being produced at a concentration dependent upon the 
cholesterol concentration and can therefore be utilized to monitor cholesterol concentration. As 
such, an increase in ECL intensity is seen with an increase in total cholesterol concentration. 
Above 5 mM, the ECL response deviates from linearity; however this is above the medical cut-
off for high cholesterol.8 The response from multiple biosensors was investigated to determine 
the reproducibility of this system and is shown in Fig. 6. 
This shows a reproducible linear response to increasing cholesterol concentrations from three 
independent biosensors, highlighting the consistent behaviour of this system. QD stability over a 
three week period was examined to give an indication of the shelf-life of this biosensor 
(supplementary information, Fig. S2). A consistent ECL response from the QDs is apparent over 
the considered period, with a drop in intensity of only 5.2% after three weeks. Response 
variability increases at the three week point, indicating biosensor reproducibility may suffer after 
this time. 
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In order to determine the clinical viability and cross-reactivity of this system, the influence of 
interferents commonly found in clinical samples (glucose, urea, citric acid) on the ECL response 
of this biosensor in 5 mM cholesterol is shown in Fig. 7. 
None of these had any appreciable effect on the observed ECL intensity indicating good sensor 
specificity. Therefore, human serum samples were spiked with increasing cholesterol 
concentrations and the response of the QD/chitosan film in each sample was measured (Fig. 8). 
A linear range from 1.5 to 4.5 mM cholesterol was examined and the ECL responses were used 
to quantify cholesterol in spiked serum samples. Table 2 described the results obtained for the 
spiked serum samples, showing an averaged recovery of 93% over the concentrations examined. 
These results show that this specific system can be used to determine cholesterol 
concentrations from human serum samples, confirming the viability of this biosensor. In order to 
progress the development of this sensor, the incubation step was removed and evaluation of the 
QD film ECL response following immobilization of ChOx on the electrode surface was 
investigated. Figure 9 shows the response of these QD/chitosan/ChOx films to increasing 
cholesterol concentrations. 
As with ChOx in solution, a peak at approximately -1.35 V vs. Ag/AgCl was observed, with 
the ECL intensity linearly dependent upon the cholesterol concentration. The linear range was 
expanded to examine the concentration range 0 mM d [cholesterol] d7 mM cholesterol. This 
suggests that the system is sufficiently sensitive to detect H2O2 even without an incubation step, 
opening up possibilities for future development into a more rapid, convenient biosensor for 
cholesterol detection.  
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CONCLUSIONS 
An ECL biosensor for the determination of total blood cholesterol was demonstrated using 
water-soluble CdSeTe/ZnS core-shell QDs. Electrodes modified with thin films containing these 
NIR ECL QDs were used to monitor the cholesterol concentrations as a result of the production 
of H2O2 during the ChOx-catalyzed oxidation of cholesterol. The ECL response showed good 
linear dependence on cholesterol concentrations over the clinically relevant range. This system 
was then successfully used to generate a linear calibration plot for cholesterol in spiked human 
serum samples and to quantify cholesterol in unknown human serum samples. As far as the 
authors know, this is one of the first ECL biosensors based on NIR emission from QD films 
examining the applicability of these sensors for blood serum analysis. The major advantage of 
this is the much improved penetrability of the ECL signal through biological samples, paving the 
way for developments in whole blood point-of-care biosensing based on these nano-architectured 
surfaces. Future studies will examine interferences, storage stability as well as pH and 
temperature effects for the integration of this biosensor in a lab-on-a-chip system. 
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LEGENDS 
Figure 1. (a) Preparation of the modified GCE by drop-casting QD/chitosan composite, (b) 
preparation of the cholesterol/ChOx solution with incubation at 45°C for 60 minutes and (c) 
generation of QD ECL signal through interaction with H2O2 co-reactant, produced in the ChOx-
catalysed oxidation of cholesterol. 
Figure 2. The ECL spectrum of CdSeTe/ZnS QDs in 2mM H2O2 at a potential of -1.5 V vs. 
Ag/AgCl. 
Figure 3. Current response for: (a) blank GCE in 0.1 M PBS (black line) and in 2 mM H2O2 (red 
line), (b) QD/chitosan film in 0.1 M PBS (black line), with 2 mM H2O2 (red line) and in 3 mM 
cholesterol (blue line) incubated with ChOx for 75 mins at 45°C. These were carried out at a 
scan rate of 100 mV s-1 over the potential range -2 V Ȟ-1 V vs. Ag/AgCl. 
 
Figure 4. (a) ECL response of QD/chitosan film to increasing H2O2 concentration (0.25 (black 
line), 0.5 (red line), 1 (blue line), 2 (pink line), 3 (green line), 4 (navy line) and 5 (navy line) 
mM) at a scan rate of 100 mV s-1 over the potential range -1.6 Ȟ-1.2 V vs. Ag/AgCl and (b) 
the linear dependence of ECL response with respect to [H2O2] for the QD/chitosan film. Error 
bars represent triplicate data points. 
Figure 5. (a) ECL response of QD/chitosan film to increasing cholesterol concentration (0.25 
(black line), 0.5 (red line), 0.75 (blue line), 1 (pink line), 1.5 (green line) and 2 (purple line) mM)  
at a scan rate of 100 mV s-1 over the potential range -1.6 Ȟ-1.2 V vs. Ag/AgCl and (b) the 
linear dependence of ECL response with respect to [cholesterol] for the QD/chitosan film. Error 
bars represent triplicate data points. 
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Figure 6. The linear dependence of ECL response with respect to [cholesterol] for 3 independent 
biosensors. 
Figure 7. Dependence of the ECL response at -1.35 V for the QD/chitosan film in 5 mM 
cholesterol with 10 mM urea, 10 mM glucose, 1 mg/mL citric acid and 10 mM uric acid. Error 
bars represent triplicate data points. 
Figure 8. Dependence of the ECL response at -1.35 V with respect to [cholesterol] for the 
QD/chitosan film in spiked human serum samples. Red line indicates background signal 
intensity. 
Figure 9. Dependence of the ECL response at -1.35 V with respect to [cholesterol] for the 
QD/chitosan/ChOx film. Error bars represent triplicate data points. Red line indicates 
background signal intensity. 
 
Table1.Absorption and emission maxima of 2 ȝM Qdot 800 ITK QDs in PBS. 
Table2.Average calculated concentrations and recoveries from unknown human serum samples. 
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FIGURE 1 
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FIGURE 2 
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FIGURE 3 
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FIGURE 4 
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FIGURE 5 
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FIGURE 6 
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FIGURE 7 
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FIGURE 8 
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FIGURE 9 
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TABLE1 
 
 
 
 
  
 Abs. maxima (nm) Emission maxima (nm) 
Qdot 800 ITK 
QDs 
n/a53 79553 
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TABLE2 
µ8QNQRZQ¶
conc. (mM) 
Average calc. 
conc. (mM) 
% Recovery 
2 1.86 93.10 
3 3.24 107.85 
4 3.63 90.82 
 
 
 
